Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1804016

registered interest
date	19/05/2025
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Negligence
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the cost of lawyers to the public purse in medical negligence cases in each of the last three years for which figures are available.
tabling member printed	Lord Bourne of Aberystwyth
uin	HL7569
answer	answer is ministerial correction date of answer 22/05/2025 answer text <p>NHS Resolution (NHSR) manages clinical negligence and other claims against the National Health Service in England. The following table shows the payments made for clinical negligence claims from 2021/22 to 2023/24:</p><table><tbody><tr><td>Financial year payment raised</td><td>NHS defendant legal costs</td><td>Claimant legal costs</td><td>Total legal costs</td><td>Compensation</td><td>Total payments including legal costs and compensation</td></tr><tr><td>2021/22</td><td>£156,935,099</td><td>£470,094,066</td><td>£627,029,165</td><td>£1,777,234,356</td><td>£2,404,263,521</td></tr><tr><td>2022/23</td><td>£159,982,259</td><td>£489,706,081</td><td>£649,688,340</td><td>£1,985,073,662</td><td>£2,634,762,002</td></tr><tr><td>2023/24</td><td>£166,889,578</td><td>£545,140,258</td><td>£712,029,836</td><td>£2,112,384,509</td><td>£2,824,414,344</td></tr></tbody></table><p>Notes:</p><ol><li>The data for 2024/25 is not yet finalised; and</li><li>annual payments for clinical negligence claims can relate to incidents which occurred many years ago, and so payments for one claim can occur over multiple years, including interim amounts paid before settlement, payments upon settlement, and annual periodic payments for some matters settled in previous years.</li></ol><p> </p><p>The rising costs of clinical negligence claims against the NHS in England are of great concern to the Government. Costs have more than doubled in the last 10 years, and are forecast to continue rising, putting further pressure on NHS finances.</p><p>The causes of the overall cost rise are complex and there is no single fix, as costs are likely to be rising because of a range of factors, including higher compensation payments and legal costs, rather than more claims or a decline in patient safety.</p><p>We recognise that this is an important issue, and ministers intend to look at all the drivers of cost.</p> answering member printed Baroness Merron question first answered 22/05/2025 09:23:00 answering member 347 label Biography information for Baroness Merron
tabling member	4282 label Biography information for Lord Bourne of Aberystwyth

1803572

registered interest
date	15/05/2025
answering body	Ministry of Housing, Communities and Local Government
answering dept id	7
answering dept short name	Housing, Communities and Local Government
answering dept sort name	Housing, Communities and Local Government
hansard heading	Local Government: Reorganisation
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to allocate the £7.6 million of capacity funding for local government reorganisation, and when that funding will be made available.
tabling member printed	Baroness Eaton
uin	HL7520
answer	answer is ministerial correction date of answer 21/05/2025 answer text <p>On 24 March the government announced it has made £7.6 million available as ‘proposal development contributions’ to support the 21 areas undergoing local government reorganisation.</p><p> </p><p>This is the first time that capacity funding has been made available for reorganisation proposals, recognising the priority that this government attaches to this. Further information will be provided on how this will be allocated soon, and we intend to make payments as soon as possible.</p> answering member printed Baroness Taylor of Stevenage question first answered 21/05/2025 11:25:26 answering member 4956 label Biography information for Baroness Taylor of Stevenage
tabling member	4184 label Biography information for Baroness Eaton

1803573

registered interest
date	15/05/2025
answering body	Ministry of Housing, Communities and Local Government
answering dept id	7
answering dept short name	Housing, Communities and Local Government
answering dept sort name	Housing, Communities and Local Government
hansard heading	Local Government: Reorganisation
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they will publish all formal correspondence with local authorities about local government reorganisation, and whether they will place copies of that correspondence in the Library of the House.
tabling member printed	Baroness Eaton
uin	HL7521
answer	answer is ministerial correction date of answer 21/05/2025 answer text <p>Useful documents, including letters to councils, announcements and news items on the local government reorganisation programme will appear on gov.uk at <a href="https://www.gov.uk/government/collections/local-government-reorganisation-policy-and-programme-updates" target="_blank">Local government reorganisation: Policy and programme updates - GOV.UK</a>. We anticipate that during this programme of local government reorganisation there will be a significant volume of correspondence with local authorities. We do not anticipate publishing all of that correspondence, nor do we consider it appropriate to place copies in the Library of the House. We will ensure that the House is updated at key moments, as we have done since the publication the English Devolution White Paper on 16 December 2024. I am of course happy to meet Noble Lords at any point.</p> answering member printed Baroness Taylor of Stevenage question first answered 21/05/2025 11:26:40 answering member 4956 label Biography information for Baroness Taylor of Stevenage attachment 1 file name Local government reorganisation Policy and programme updates - GOV.UK.pdf title Local government reorganisation
tabling member	4184 label Biography information for Baroness Eaton

1803575

registered interest
date	15/05/2025
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Obesity: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the impact of GLP-1 drugs on combatting and preventing disease.
tabling member printed	Lord Bourne of Aberystwyth
uin	HL7509
answer	answer is ministerial correction date of answer 22/05/2025 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for licensing medicines, such as GLP-1s, based on an assessment of their safety, quality, and efficacy. The National Institute of Health and Care Excellence (NICE) then appraises licensed medicines based on an assessment of their clinical and cost-effectiveness, and makes recommendations on whether they can be recommended for routine use on the National Health Service. The NHS in England is legally required to fund medicines recommended in a NICE appraisal, usually within three months of final guidance.</p><p>The MHRA only assesses medicines within the indications for which companies submit evidence. Any extension of a medicine’s licence to cover additional indications would require a separate evidence submission. Similarly, the NICE only appraises medicines within their licensed indications.</p><p>There are a number of GLP-1s licensed for use in weight management, type 2 diabetes, and for cardiovascular risk reduction for adults who are overweight or obese. The NICE has recommended them as a clinically and cost effective option, when prescribed alongside diet, physical activity, and behavioural support, to support some people living with obesity to lose weight. For those living with obesity, weight loss can provide significant health benefits, reducing the risk of developing certain diseases as well as improving the management of some existing weight related conditions.</p><p>There is also research exploring the role of GLP-1 drugs for the treatment and prevention of wider diseases, including cardiovascular disease, dementia, and cancer, and health related behaviours, including alcohol and nicotine intake. The MHRA and the NICE will consider the effectiveness and cost effectiveness of any wider use of GLP-1 medicines should evidence be submitted to them.</p> answering member printed Baroness Merron question first answered 22/05/2025 09:18:07 answering member 347 label Biography information for Baroness Merron
tabling member	4282 label Biography information for Lord Bourne of Aberystwyth

1803588

registered interest
date	15/05/2025
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what proportion of medical radioisotopes used to treat cancer in the UK are produced by (1) a reactor-based method, and (2) close to hospital cyclotron manufacture.
tabling member printed	Lord Wigley
uin	HL7548
answer	answer is ministerial correction date of answer 22/05/2025 answer text <p>Medical radioisotopes can be produced in different ways and the cyclotrons used in the United Kingdom produce a small supply of medical radioisotopes, mainly for diagnostic use. This is because the cyclotrons used in the UK supply relatively low-level radioactive material which is best suited for imaging and diagnosis. For therapeutics, particle emitting radioisotopes tend to be used. For UK use, these are mainly manufactured in research reactors, and there are currently no reactors in the UK that manufacture these isotopes. Research reactors can also supply medical radioisotopes for imaging and diagnosis.</p><p>Medical radioisotopes are purchased from suppliers on trust and hospital levels, and the Department has not made a systematic review of the origin country for these products.</p> answering member printed Baroness Merron grouped question UIN HL7549 question first answered 22/05/2025 09:19:48 answering member 347 label Biography information for Baroness Merron
tabling member	547 label Biography information for Lord Wigley

1803589

registered interest
date	15/05/2025
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what proportion of reactor-produced radioisotopes used for treatment of cancer in the UK are provided from (1) the European Union, (2) Australia, (3) Argentina, and (4) the rest of the world.
tabling member printed	Lord Wigley
uin	HL7549
answer	answer is ministerial correction date of answer 22/05/2025 answer text <p>Medical radioisotopes can be produced in different ways and the cyclotrons used in the United Kingdom produce a small supply of medical radioisotopes, mainly for diagnostic use. This is because the cyclotrons used in the UK supply relatively low-level radioactive material which is best suited for imaging and diagnosis. For therapeutics, particle emitting radioisotopes tend to be used. For UK use, these are mainly manufactured in research reactors, and there are currently no reactors in the UK that manufacture these isotopes. Research reactors can also supply medical radioisotopes for imaging and diagnosis.</p><p>Medical radioisotopes are purchased from suppliers on trust and hospital levels, and the Department has not made a systematic review of the origin country for these products.</p> answering member printed Baroness Merron grouped question UIN HL7548 question first answered 22/05/2025 09:19:48 answering member 347 label Biography information for Baroness Merron
tabling member	547 label Biography information for Lord Wigley

1803592

registered interest
date	15/05/2025
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Reservoirs: Wales
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the remarks by Lord Katz on 14 May (HL Deb col 2181), which powers the Welsh Government and Senedd Cymru have over the construction and extension of reservoirs in Wales for the supply of water to English conurbations.
tabling member printed	Lord Wigley
uin	HL7551
answer	answer is ministerial correction date of answer 21/05/2025 answer text <p>Both the UK Government and Welsh Government’s should act in accordance with the Intergovernmental Protocol on Water Resources, Water Supply and Water Quality in having regard to the interests of water consumers on the other side of the border in the exercise of their functions.</p><p> </p><p>Planning consents for water resources infrastructure projects in Wales, such as reservoirs, are devolved to the Welsh Government. Where project proposals may affect cross-border links, applicants should work with the relevant administrations and regulatory organisations.</p> answering member printed Baroness Hayman of Ullock question first answered 21/05/2025 15:34:21 answering member 4395 label Biography information for Baroness Hayman of Ullock
tabling member	547 label Biography information for Lord Wigley

1803169

registered interest
date	14/05/2025
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Peatlands: Conservation
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what action they are taking to protect peatlands.
tabling member printed	Lord Bourne of Aberystwyth
uin	HL7467
answer	answer is ministerial correction date of answer 20/05/2025 answer text <p>The Government recognises the importance of England’s peatlands and committed in our manifesto to expanding nature-rich habitats including bogs. We have ambitions to restore hundreds of thousands of hectares of peatland across the country.</p><p> </p><p>Defra is currently seeking views on proposed changes to <a href="https://www.legislation.gov.uk/uksi/2021/158/contents/made" target="_blank">The Heather and Grass etc. Burning (England) Regulations 2021</a>, which would provide protection to a broader area of upland peat. A <a href="https://www.gov.uk/government/consultations/heather-and-grass-burning-in-england" target="_blank">public consultation</a> was launched on 31 March and will close on 25 May, the results of which will be used to inform future policy in this area.</p><p> </p><p>We are also looking at next steps regarding measures to ban horticultural peat and will continue to work alongside the horticultural sector to accelerate progress on the peat free transition.</p> answering member printed Baroness Hayman of Ullock question first answered 20/05/2025 15:17:30 answering member 4395 label Biography information for Baroness Hayman of Ullock attachment 1 file name The Heather and Grass etc. Burning (England) Regulations 2021.pdf title Heather + Grass Burning Regulations
tabling member	4282 label Biography information for Lord Bourne of Aberystwyth

1803177

registered interest
date	14/05/2025
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Employment
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of labour market data released by the Office for National Statistics on 15 April showing a decline in payrolled employment; and what part the recent changes in employer National Insurance contributions played in that decline.
tabling member printed	Lord Rose of Monewden
uin	HL7488
answer	answer is ministerial correction date of answer 21/05/2025 answer text <p>The latest provisional estimates of payrolled employee numbers from HMRC Real Time Information show there were 30.3 million employees on Payrolls in April. Payrolled employee numbers fell by 33,000 on the month and 106,000 on the year in April 2025.</p><p><strong> </strong></p><p>The Office for Budget Responsibility (OBR) provides independent economic forecasts and assesses the impact of government policy decisions. With all policies considered, the OBR's March 2025 EFO forecasts the employment level to increase from 33.6 million in 2024 to 34.8 million in 2029.</p><p> </p> answering member printed Lord Livermore question first answered 21/05/2025 13:36:49 answering member 4559 label Biography information for Lord Livermore
tabling member	4326 label Biography information for Lord Rose of Monewden

1803179

registered interest
date	14/05/2025
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Business
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the decline in business confidence reported by the IoD Directors’ Economic Confidence Index and the Business Confidence Monitor of the Institute of Chartered Accountants in England and Wales; and to what extent this decline has been influenced by (1) the Employment Rights Bill, (2) rises in employer National Insurance contributions, and (3) rises in business rates.
tabling member printed	Lord Rose of Monewden
uin	HL7489
answer	answer is ministerial correction date of answer 21/05/2025 answer text <p>The Government monitors a wide range of indicators to assess the UK’s economic performance. Multiple surveys and indicators are released by different data providers every month. Many of these are volatile and can move materially from month to month.</p><p> </p><p>Official economic forecasts and assessments of policy impacts are set out in the Office for Budget Responsibility’s Economic and Fiscal Outlook documents, the most recent of which was published in March 2025.</p> answering member printed Lord Livermore question first answered 21/05/2025 13:36:23 answering member 4559 label Biography information for Lord Livermore
tabling member	4326 label Biography information for Lord Rose of Monewden